- Report
- October 2023
- 200 Pages
Global
From €5736EUR$5,950USD£4,906GBP
- Report
- May 2024
- 89 Pages
Global
From €5399EUR$5,600USD£4,617GBP
- Report
- February 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- February 2024
- 110 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- November 2023
- 200 Pages
Global
€4816EUR$4,995USD£4,119GBP
- Report
- September 2020
- 700 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- January 2020
- 508 Pages
Global
From €4723EUR$4,899USD£4,039GBP
- Report
- January 2020
- 300 Pages
Global
From €3182EUR$3,300USD£2,721GBP
- Report
- July 2019
- 189 Pages
Global
From €1326EUR$1,375USD£1,134GBP
€2651EUR$2,750USD£2,267GBP
- Report
- June 2020
- 248 Pages
Global
From €4772EUR$4,950USD£4,081GBP
- Report
- March 2023
- 139 Pages
Global
From €5303EUR$5,500USD£4,535GBP
- Report
- December 2021
- 206 Pages
Global
From €2651EUR$2,750USD£2,267GBP
€5303EUR$5,500USD£4,535GBP
- Clinical Trials
- July 2019
- 170 Pages
Global
From €2892EUR$3,000USD£2,474GBP
- Report
- April 2022
- 80 Pages
Africa
From €3659EUR$3,795USD£3,129GBP
- Report
- April 2022
- 40 Pages
Brazil
From €2502EUR$2,595USD£2,140GBP
- Report
- April 2022
- 40 Pages
China
From €2502EUR$2,595USD£2,140GBP
- Report
- April 2022
- 40 Pages
France
From €2502EUR$2,595USD£2,140GBP
- Report
- April 2022
- 40 Pages
Germany
From €2502EUR$2,595USD£2,140GBP
- Report
- April 2022
- 40 Pages
India
From €2502EUR$2,595USD£2,140GBP
- Report
- April 2022
- 40 Pages
Ireland
From €2502EUR$2,595USD£2,140GBP
The Cancer Stem Cell (CSC) market is a subset of the larger stem cell market. CSCs are a type of stem cell that can cause cancer when they divide and grow uncontrollably. CSCs are believed to be responsible for the recurrence of cancer after treatment, and are the focus of much research into new treatments. CSCs are also being studied for their potential to be used in regenerative medicine.
CSCs are being studied for their potential to be used in personalized medicine, where treatments are tailored to the individual patient. CSCs are also being studied for their potential to be used in drug discovery and development, as they can be used to test the effectiveness of new drugs.
The CSC market is a rapidly growing field, with many companies investing in research and development. Companies such as Celgene, Novartis, and AstraZeneca are investing in CSC research, while companies such as Thermo Fisher Scientific and Bio-Rad are providing tools and services to support CSC research. Other companies such as StemCell Technologies and STEMCELL Technologies are providing products and services to support CSC research. Show Less Read more